O'Shaughnessy Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.43M Sell
174,136
-91,295
-34% -$4.96M 0.03% 452
2026
Q1
$16.7M Sell
265,431
-11,558
-4% -$925K 0.08% 260
2025
Q4
$26.4M Sell
276,989
-13,096
-5% -$1.28M 0.15% 147
2025
Q3
$28.3M Buy
290,085
+8,312
+3% +$861K 0.17% 126
2025
Q2
$30.3M Buy
281,773
+19,276
+7% +$1.95M 0.21% 98
2025
Q1
$26.5M Buy
262,497
+22,757
+9% +$2.29M 0.21% 103
2024
Q4
$21.4M Buy
239,740
+23,605
+11% +$2.08M 0.18% 120
2024
Q3
$18.9M Buy
216,135
+16,701
+8% +$1.32M 0.17% 136
2024
Q2
$15.4M Buy
199,434
+29,769
+18% +$2.18M 0.16% 136
2024
Q1
$11.6M Buy
169,665
+11,021
+7% +$709K 0.13% 181
2023
Q4
$9.17M Buy
158,644
+21,468
+16% +$1.15M 0.12% 188
2023
Q3
$7.24M Buy
137,176
+10,058
+8% +$528K 0.11% 218
2023
Q2
$6.88M Buy
127,118
+24,838
+24% +$1.3M 0.1% 217
2023
Q1
$5.12M Buy
102,280
+54,117
+112% +$2.55M 0.08% 272
2022
Q4
$2.23M Buy
48,163
+7,464
+18% +$323K 0.04% 411
2022
Q3
$1.58M Buy
40,699
+17,392
+75% +$698K 0.03% 453
2022
Q2
$869K Sell
23,307
-7,345
-24% -$299K 0.02% 556
2022
Q1
$1.36M Buy
30,652
+12,983
+73% +$563K 0.02% 467
2021
Q4
$751K Sell
17,669
-2,988
-14% -$126K 0.01% 583
2021
Q3
$896K Buy
20,657
+6,258
+43% +$277K 0.02% 495
2021
Q2
$616K Buy
14,399
+1,909
+15% +$80.3K 0.01% 594
2021
Q1
$483K Buy
12,490
+901
+8% +$34.1K 0.01% 621
2020
Q4
$417K Sell
11,589
-2,091
-15% -$75.4K 0.01% 573
2020
Q3
$523K Buy
13,680
+2,952
+28% +$114K 0.02% 435
2020
Q2
$377K Buy
10,728
+9,954
+1,286% +$358K 0.01% 472
2020
Q1
$25K Sell
774
-1,730
-69% -$67.6K ﹤0.01% 898
2019
Q4
$113K Buy
2,504
+2,500
+62,500% +$105K ﹤0.01% 757
2019
Q3
$0 Hold
4
﹤0.01% 994
2019
Q2
$0 Buy
+4
New +$154 ﹤0.01% 988

Other funds holding BSX

O'Shaughnessy Asset Management's BSX Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Boston Scientific (BSX) stake by 34% in Q2 2026, selling an estimated $4.96M and leaving 174,136 shares worth $7.43M. The position accounts for 0.03% of the portfolio, ranked #452.

O'Shaughnessy Asset Management first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $30.3M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • O'Shaughnessy Asset Management held 174,136 shares of Boston Scientific worth $7.43M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 91,295 Boston Scientific shares in Q2 2026, an estimated $4.96M.
  • Boston Scientific made up 0.03% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #452 holding.
  • O'Shaughnessy Asset Management first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
  • O'Shaughnessy Asset Management's Boston Scientific position peaked at $30.3M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.